Todd Christopher Longsworth - General Counsel at NovoCure Ltd

Issuer-level insider activity

Role
General Counsel
Issuer ticker
NVCR on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Todd Christopher Longsworth since 13 Jul 2025

Reported holdings for Todd Christopher Longsworth in NovoCure Ltd

Form 4 holding General Counsel

NovoCure Ltd

Security class
Ordinary Shares
Shares / value
62,462
Estimated value
$790,144
Report date
08 Mar 2022
Price
$12.65
Ownership
Direct
Form 4 holding General Counsel

NovoCure Ltd

Security class
Options to Buy Ordinary Shares
Shares / value
6,106
Estimated value
$69,975
Report date
03 Mar 2022
Price
$11.46
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Todd Christopher Longsworth in NovoCure Ltd

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .